Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)

    This grant aims to support new entrepreneurs in small businesses by developing their entrepreneurial skills while conducting research under their direction.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant is no longer accepting proposals

    National Institutes of Health has archived this opportunity.

    Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)

    The NIH will soon offer grants to support early-career scientists at US small businesses, funding both research and entrepreneurial training, with required mentoring for first-time principal investigators.

    HHS-NIH11Forecasted Jan 5, 2027Forecasted

    Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)

    This upcoming NIH and CDC grant supports early-career scientists at US small businesses with funding, entrepreneurial training, and mentoring to help them transition into entrepreneurship.

    HHS-NIH11Forecasted Jan 5, 2027Forecasted

    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

    NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.

    HHS-NIH11Due Feb 16, 2027$275,000

    Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)

    NIH supports graduate students completing doctoral research and transitioning to mentored postdoctoral training; candidates may gain clinical trial experience but cannot lead an independent trial.

    HHS-NIH11Due Dec 8, 2026

    Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

    NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.

    HHS-NIH11Forecasted Jul 31, 2027Forecasted